StonvexLoading…
StonvexStonvexStonvexCore line items from ENOV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q2 2026 2026-04-03 | Annual 2025 2025-12-31 | Q4 2025 2025-10-03 | Q3 2025 2025-07-04 |
|---|---|---|---|---|
Revenue | $589.15M | $2.25B | $1.67B | $1.12B |
Operating Income | $6.53M | $-1.12B | $-622.05M | $-63.56M |
Net Income | $-8.76M | $-1.18B | $-663.85M | $-92.70M |
EPS (Diluted) | $-0.15 | $-20.75 | $-11.64 | $-1.62 |
Total Assets | $3.83B | $3.83B | $4.43B | $5.02B |
Total Liabilities | $2.35B | $2.34B | $2.41B | $2.44B |
Cash & Equivalents | $33.13M | $36.39M | $33.62M | $44.07M |
Free Cash Flow OCF − CapEx | $-28.85M | $19.92M | $-12.37M | $-41.46M |
Shares Outstanding | 57.55M | 57.19M | 57.19M | 57.16M |